Related Experiment Video

Updated: Oct 17, 2026

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

The use of LCMV-specific T cell hybridomas for the quantitative analysis of MHC class I restricted antigen

K Schwarz, M van den Broek, R de Giuli

    Journal of Immunological Methods
    |March 22, 2000
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining06:25

    Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining

    Published on: December 23, 2016

    Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation12:09

    Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

    Published on: February 28, 2019

    Related Concept Videos

    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation, polyethylene glycol...